Evidence map›Paper›PMID 41131384›Full record

ArticleEuropean journal of human genetics : EJHG2026

RP9 revisited; RP9 p.(H137L) remains a likely cause of dominant splicing factor-Retinitis Pigmentosa.

Leon Chang, James A Poulter, Andrew R Webster, Gavin Arno, Rajarshi Mukherjee, Andrew Lotery, Alison J Hardcastle, Christopher M Watson, Chris F Inglehearn

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Leon Chang *Leeds Institute of Medical Research, School of Medicine, University of Leeds, Leeds, UK.ORCID 0009-0003-5223-7616
James A Poulter *Leeds Institute of Medical Research, School of Medicine, University of Leeds, Leeds, UK.ORCID 0000-0003-2048-5693
Andrew R WebsterNIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust & UCL Institute of Ophthalmology, London, UK.
Gavin ArnoNIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust & UCL Institute of Ophthalmology, London, UK.ORCID 0000-0002-6165-7888
Rajarshi MukherjeeDepartment of Ophthalmology, St. James's University Hospital, Leeds, UK.ORCID 0000-0002-8707-6248
Andrew LoterySouthampton Eye Unit, University Hospital Southampton, Southampton, UK.ORCID 0000-0001-5541-4305
Alison J HardcastleNIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust & UCL Institute of Ophthalmology, London, UK.ORCID 0000-0002-0038-6770
Christopher M WatsonLeeds Institute of Medical Research, School of Medicine, University of Leeds, Leeds, UK.ORCID 0000-0003-2371-1844
Chris F InglehearnLeeds Institute of Medical Research, School of Medicine, University of Leeds, Leeds, UK. c.inglehearn@leeds.ac.uk.ORCID 0000-0002-5143-2562

Funding

Wellcome Trust
6 · The paper itself

Abstract

Variants in six pre-mRNA processing factors cause autosomal dominant Retinitis Pigmentosa (adRP). The RP9 gene encodes a seventh splicing factor, and in 2002, we published RP9 variants c.410A>T; p.(H137L) and c.509A>G; p.(D170G) as likely causes of adRP in a large multigenerational RP9-linked family and a single case, respectively. It has since been suggested these variants might be artefacts due to simultaneous amplification of the RP9P pseudogene, and no further pathogenic variants have been reported. We therefore rescreened two members of the RP9-linked family by genome sequencing. Examination of the 2 Mb locus defined by crossovers in the original family revealed no other plausible causative variants. Alignment of both short and long-read sequences confirmed that p.(H137L) is in the RP9 gene, not the pseudogene. Screening for p.(H137L) in 1961 RP/Rod-cone dystrophy (RCD) cases from the Leeds patient cohort and UK 100,000 Genomes Project (100kGP) database revealed four further carriers. Including the original family, this variant was therefore present in 5/1962 RP/RCD probands, and is absent from gnomAD, constituting statistically significant enrichment in RP cases. Long-read sequencing of p.(H137L) in available carriers showed this is a UK founder allele. The RP9 p.(D170G) allele was also confirmed as gene, not pseudogene, derived, but is present in 22 individuals in the 100kGP cohort, none with RP, as well as >200 individuals in gnomAD and Biobank, suggesting it is non-pathogenic. In conclusion, RP9 p.(H137L) is strongly associated with RP and remains the only plausible variant accounting for the condition in a large multi-generation adRP family.

Indexed as

Eye ProteinsRetinitis PigmentosaAdultFemaleHumansMaleMiddle AgedPedigreeEye Proteins

Identifiers

PMID41131384
PMCPMC12858846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.